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Host-derived matrix metalloproteinases (MMPs) and bacterial proteases mediate destruction of 
extracellular matrices and supporting alveolar bone in periodontitis. The Treponema denticola 
dentilisin protease induces MMP-2 expression and activation in periodontal ligament (PDL) 
cells, and dentilisin-mediated activation of pro-MMP-2 is required for cellular fibronectin 
degradation. Here we report that T. denticola regulates MMP-2 expression through epigenetic 
modifications in the periodontium. PDL cells were treated with epigenetic enzyme inhibitors 
before or after T. denticola challenge. Fibronectin fragmentation, MMP-2 expression and 
activation were assessed by immunoblot, zymography and qRT-PCR, respectively. Chromatin 
modification enzyme expression in T. denticola-challenged PDL cells and periodontal tissues 
were evaluated using gene arrays. Several classes of epigenetic enzymes showed significant 
alterations in transcription in diseased tissue and T. denticola-challenged PDL cells. T. denticola-
mediated MMP-2 expression and activation were significantly reduced in PDL cells treated with 
inhibitors of aurora kinases and histone deacetylases. In contrast, DNA methyltransferase 
inhibitors had little effect, and inhibitors of histone acetyltransferases, methyltransferases and 
demethylases exacerbated T. denticola-mediated MMP-2 expression and activation. Chronic 
epigenetic changes in periodontal tissues mediated by T. denticola or other oral microbes may 
contribute to the limited success of conventional treatment of chronic periodontitis and may be 
amenable to therapeutic reversal. 









Periodontitis, a bacterially-mediated chronic inflammatory disease of the tissues supporting 
the tooth is one of the most common inflammatory diseases in humans and it can adversely affect 
systemic health (Armitage, 2004, Armitage, 2008). National surveys show that the majority of 
adults suffer from mild-to-moderate periodontitis, with up to 15% of the population being 
affected by severe forms at some stage in their lives (Pihlstrom et al., 2005). Periodontitis causes 
largely irreversible destruction of the periodontal tissues, and in advanced stages, tooth loss, 
speech and masticatory problems, and an overall reduced quality of life. Moreover, the systemic 
burden of periodontitis on different organs has been investigated. It has been reported that 
periodontal infections can adversely predispose to coronary heart diseases (Stewart et al., 2016), 
ischemic strokes (Leira et al., 2016), poor glycemic control (Garcia et al., 2015), preterm labor, 
low-birth-weight delivery (Sitholimela et al., 2013), and pulmonary diseases (Prasanna, 2011). 
These systemic effects have been attributed to either direct bacterial invasion or modulation of 
specific host inflammatory and tissue destructive mediators (Williams et al., 2008).  
Destruction of the periodontal extracellular matrices (ECM) and detrimental changes in the 
cellular elements of the periodontal ligament occur as a result of disruption of normal tissue 
homeostatic processes. One of these disrupted processes is regulation of host-derived matrix 
metalloproteinases (MMP) that are both directly and indirectly involved in periodontal tissue 
breakdown. Destruction of the ECM in periodontitis results in the release of fibronectin (FN) 
fragments, which are considered markers of periodontal disease status (Huynh et al., 2002). 
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Evidence from in vitro studies further indicate that these FN fragments, induce several 
detrimental effects, including induction of apoptosis and suppression of osteoblast differentiation 
of periodontal ligament cells (Kapila et al., 1996, Kapila et al., 1998, Kapila et al., 1999, Jee et 
al., 2004, Dai et al., 2005, Ghosh et al., 2008, Joseph et al., 2010), thereby further potentiating 
disease progression.   
MMPs are synthesized in latent form, then activated through proteolytic cleavage to expose 
the catalytic site of the MMP enzyme. MMP activation is primarily extracellular, though 
intracellular activation is reported in certain cases (Nagase, 1997, Murphy et al., 1999). MMPs 
are synthesized at low basal levels for maintenance of homeostatic processes; however their 
levels and activation are typically increased during disease (Mittal et al., 2016). In addition to 
their role in remodeling the ECM and basement membrane during various physiologic processes, 
MMPs are implicated in a wide range of pathologic processes, including cardiovascular 
(Azevedo et al., 2014), pulmonary (Navratilova et al., 2016, Pardo et al., 2016), renal (Aresu et 
al., 2011, Charitaki et al., 2016), and gastrointestinal diseases (Medina et al., 2004), cancer 
(Endres et al., 2016, Ligi et al., 2016, Liu et al., 2016, Lukaszewicz-Zajac et al., 2016, 
Pietruszewska et al., 2016) and inflammatory diseases, such as periodontitis (Shinkarenko et al., 
2013, Nissinen et al., 2014). 
MMP-2, one of several MMPs involved in tissue homeostasis and remodeling, is 
constitutively expressed by periodontal ligament cells as pro-MMP-2 (Kapila et al., 1996). Thus, 
control of the process or rate of activation of MMP- 2 has been proposed as a key regulatory step 
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in periodontal tissue homeostasis (Madsen et al., 2013, Mosig et al., 2013, Borkham-Kamphorst 
et al., 2015). Activation of pro-MMP-2 is promoted by proteolytic cleavage by the membrane 
type-1-MMP (MT1-MMP/MMP-14) (Nagase, 1997, Murphy et al., 1999, Zucker et al., 2003). 
Extracellular MMP activities are controlled by the blockage of autolytic MMP activation or by 
endogenous proteinase inhibitors, such as tissue inhibitors of MMPs (TIMPs) (Nagase et al., 
2006, Brew et al., 2010). Regulation of the proteolytic activity of MMP-2 is dependent on the 
balance between MT1-MMP/TIMP-2 (Shofuda et al., 1998, Hernandez-Barrantes et al., 2001, 
Oyarzun et al., 2010). This mechanism of MMP-2 activation by an MT1-MMP–TIMP-2 
complex has been well recognized in other systems (Strongin et al., 1995, Butler et al., 1998, 
Kinoshita et al., 1998).  Disturbances in that balance may result in excessive tissue degradation 
associated with inflammatory diseases (Ejeil et al., 2003). 
T. denticola along with Porphyromonas gingivalis and Tannerella forsythia become prevalent 
in late stages of subgingival biofilm formation and comprise the bacterial “red complex” that is 
considered pathogenic in the etiology of periodontal disease (Socransky et al., 1998). While our 
understanding of the periodontal disease microbiome has greatly increased, the “red complex” 
bacteria continue to be recognized as important pathogens in the disease process. Oral 
spirochetes including T. denticola often predominate in periodontal disease, though they are 
typically below detectable levels in healthy gingival plaque (Choi et al., 1994, Ellen et al., 2005). 
The levels of T. denticola increase with the severity of periodontitis, underscoring its major role 
in the disease (Simonson et al., 1988, Yoshida et al., 2004). 
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Recognized virulence factors of T. denticola include the acylated serine protease complex 
(dentilisin; PrtP complex; CTLP/chymotrypsin-like protease) that degrades gelatin, laminin and 
various serum components and bioactive peptides (Uitto et al., 1988, Grenier et al., 1990, 
Makinen et al., 1995). The dentilisin complex contributes to T. denticola adherence and 
cytotoxic effects on epithelial cells and fibroblasts (Ellen et al., 1994, Mathers et al., 1996, 
Fenno et al., 1998), penetration of epithelial tissue (Chi et al., 2003), and it may play a role in 
complement-mediated bactericidal activity (McDowell et al., 2009) and complement evasion 
(McDowell et al., 2011). Of particular relevance to the current study, we previously 
demonstrated that dentilisin proteolytic activity induces activation of pro-MMP-2 in cultured 
PDL cells, and that activated MMP-2 is required for cleavage of cellular FN into fragments 
similar to those observed in gingival crevicular fluid from periodontal lesions (Miao et al., 
2011). Furthermore, transcription and expression of MT1/MMP and TIMP-2 increased in 
response to T. denticola challenge (Miao et al., 2014). Taken together, these properties suggest 
important links between the T. denticola protease activity and regulation of the cellular and 
tissue processes that result in periodontal tissue destruction. 
Epigenetics is defined as heritable and potentially reversible changes in gene expression 
without alterations in the DNA sequence (Goldberg et al., 2007, Waddington, 2012). Such 
modifications are not only associated with diseases but are also essential for the incorporation 
and integration of endogenous and environmental signals in cells. Epigenetic status can be 
affected by environmental factors, such as, nutrients, toxins, infections, and hypoxia with 
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subsequent up- or down-regulation of specific gene expression patterns (Barros et al., 2009, 
Safronova et al., 2010, Bayarsaihan, 2011, Yin et al., 2011). Emerging evidence suggests that 
epigenetic modifications play a major role in inflammatory diseases, including periodontal 
disease (Barros et al., 2014). Several factors that mediate periodontal disease pathogenesis, 
including bacteria and their byproducts, smoking, and diabetes, induce marked epigenetic 
changes in tissue components (Offenbacher et al., 2008, Khansari et al., 2009, Medzhitov et al., 
2009, Yin et al., 2011, Razzouk et al., 2013, Martinez et al., 2014, Pasquier et al., 2015). For 
example, chronically inflamed periodontal tissues demonstrated an increased methylation of 
CpG-rich regions of the PTGS2/COX2 promoter compared to healthy periodontal tissues (Zhang 
et al., 2010). Also, there is marked hypomethylation of the IL8 promoter in oral epithelial cells 
of subjects with Generalized Aggressive Periodontitis compared to control subjects (Andia et al., 
2010). Emerging studies suggest that microbial pathogens, including oral species such as 
Porphyromonas gingivalis, induce epigenetic modifications in host cells (reviewed in (Niller et 
al., 2017)). We recently identified potential epigenetic links between T. denticola and genes in 
PDL cells involved in activation of MMP-2 (Miao et al., 2014). Thus, T. denticola may mediate 
epigenetic modifications that regulate MMP-2 activation and subsequent ECM degradation in the 
periodontium.  
Epigenetic modifications are potentially reversible, and, therefore, a thorough understanding 
of these changes may identify new therapeutic targets for disease management. The aim of this 
study was to investigate T. denticola’s ability to chronically activate MMP expression through 
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epigenetic modifications in periodontal ligament cells/tissues, and to examine potential 
therapeutic approaches for reversal/modification of these changes. 
 
Results 
T. denticola chronically upregulates expression of MMP-2, MT1-MMP and TIMP-2, 
with concomitant fibronectin fragmentation. To determine the long-term effects of a brief 
exposure to T. denticola on MMP-2 expression in host cells, PDL cells were briefly challenged 
with T. denticola, then MMP-2 expression and MMP-2 activation in long-term cultures with 
daily medium changes were assessed by gelatin zymography and qRT-PCR. As shown in Fig. 
1A, PDL cells constitutively expressed basal levels of pro-MMP-2 with minimal activation for 
maintenance of homeostatic functions. However, challenge with T. denticola triggered both 
chronic increased MMP-2 expression (pro-MMP2) and activation (active MMP-2) in PDL cells. 
Following a 2h exposure to T. denticola, dentilisin activity (visible as a ~100kDa band on the 
zymogram, Fig. 1A) persisted within these cultures throughout the experiment, though it was 
detected at greatly reduced levels at days 9 and 12. Expression and activation levels of MMP-2 
were chronically sustained for up to 12 days, with minor reductions in the levels of activated 
MMP-2 on days 9 and 12 (Fig. 1A). T. denticola-mediated increases in MMP-2 expression and 
activation were mirrored by concomitant fibronectin fragmentation throughout the experiment 
(Fig. 1B).  
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The chronic effects of T. denticola on MMP-2 expression in PDL cells were regulated at the 
transcriptional level. MMP-2 mRNA levels were upregulated for up to 12 days as assessed by 
qRT-PCR (Fig. 1C). Given that the MT1-MMP/TIMP-2 complex is a well-known regulator of 
MMP-2 activation, MT1-MMP and TIMP-2 expression were examined in T. denticola 
challenged periodontal ligament cells in long-term cultures. Expression of the MT1-
MMP/TIMP-2 complex was also chronically upregulated by the T. denticola challenge, 
mirroring the changes induced in MMP-2 transcriptional expression (Fig. 1C).  
T. denticola levels and MMP-2 transcription are elevated in periodontal disease. 
Examination of human tissues from periodontally diseased and healthy sites confirmed the 
association between T. denticola and elevated MMP-2 expression in diseased tissues. Human 
tissue specimens from periodontally diseased sites exhibited elevated levels of T. denticola 
concomitant with elevated levels of MMP-2 mRNA expression compared with healthy sites (Fig. 
2). Tissue specimens from healthy sites exhibited negligible levels of T. denticola and low levels 
of MMP-2 expression. Low levels of MMP-2 expression in healthy tissues are consistent with 
the low basal levels of MMP-2 expression necessary for homeostatic functions within the 
periodontium, while increased MMP-2 expression is consistent with dysbiotic alterations of 
periodontal homeostasis in disease. 
Expression of genes encoding chromatin modification enzymes are significantly altered 
in periodontal disease. To further examine the role of epigenetics in periodontal disease, the 
major chromatin modification enzymes that might be involved in the disease process (Table S1) 
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were assessed via a focused gene array. Applying a “2-fold change” as a threshold value, we 
found that several chromatin modification enzymes were significantly altered in diseased 
periodontal tissue specimens compared to healthy control tissues (Fig. 3A, B and Table S2). The 
most significantly altered enzymes were the histone methyltransferases (HMTs) and histone 
deacetylases (HDACs), including PRMT8 and HDAC11, which exhibited a significant down-
regulation. Other enzymes, especially those related to SET Domain proteins, histone 
acetyltransferases (HATs), and histone phosphorylation kinases showed significant up-
regulation, such as SETD4, ESCO1, ESCO2, and AURKB. Other significantly altered enzymes 
included HATs, HDACs, histone ubiquitinases, DNA demethylases (DDMs) and histone 
demethylases (HDMs), and DNA methyltransferases (DNMTs).  
T. denticola significantly alters expression of genes encoding chromatin modification 
enzymes in PDL cells. To examine the potential role of epigenetics in the T. denticola-mediated 
upregulation of MMP-2 expression, a focused gene array was employed to study all major 
epigenetic chromatin modification enzymes that might be involved in this process (Table S1). 
Applying a “2-fold change” as a threshold value, we found that T. denticola-challenged PDL 
cells exhibited significantly decreased levels of all major chromatin modification enzymes (and 
Fig. 3C, D and Table S3). No chromatin modifying enzymes assayed showed increased 
expression (data not shown). The most significantly down-regulated enzymes included aurora 
kinases, which mediate histone phosphorylation, and HMTs. Specifically, within these classes of 
enzymes, the most downregulated enzymes included Aurora Kinase B and EHMT2. Other 
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significantly downregulated enzymes included HATs, histone deacetylases (HDAC), histone 
ubiquitinases, DNA (DDM) and histone demethylases (HDM), and DNMTs.  
Inhibitors of histone kinase/aurora kinase, DNMT and HDAC block T. denticola-
mediated increases in MMP-2 activity and expression in PDL cells. Given the broad 
landscape of epigenetic changes mediated by T. denticola on PDL cells and the changes 
exhibited in diseased tissues, targeted approaches were employed to examine the role of 
representative members of each major class of epigenetic enzymes (Table 1) in the process of 
MMP-2 modulation and FN fragmentation in T. denticola-challenged PDL cells.  
Pretreatment of PDL cells with the histone kinase/phosphorylation inhibitor, PF-03814735, 
inhibited the potential increase in MMP-2 activation and expression mediated by T. denticola 
(Fig. 4 A to C). Pretreatment with PF-03814735 also prevented the transcriptional increase in the 
MMP-2 activator complex, MT1-MMP /TIMP-2, and FN fragmentation mediated by the T. 
denticola challenge. This aurora kinase inhibitor exhibited a dose-response effect in terms of 
preventing the changes in MMP-2 expression and activation. At the highest dose tested, PF-
03814735 also suppressed MMP-2 expression and activation in control cells. All enzyme 
inhibitor concentrations were selected in ranges that did not alter proliferation or induce 
cytotoxicity in PDL cells (data not shown). 
Prevention of the potential increase in MMP-2 activation and expression mediated by T. 
denticola was also achieved by pretreatment of PDL cells with Azacytidine (AZA), a DNMT 
inhibitor (Fig. 5 A to C). AZA had a dose-response effect, inhibiting increases in MMP-2 
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expression and activation, MT1-MMP/TIMP-2 expression, and fibronectin fragmentation 
mediated by the T. denticola challenge. In contrast, epigallocatechin gallate (EGCG), a different 
DNMT inhibitor with a broad spectrum of activity that includes inhibition of HATs, had 
considerably less effect than AZA. At the highest concentration tested, EGCG had only minor 
effects on T. denticola-mediated MMP-2 activation and TIMP-2 expression, but this did not 
result in modulation of FN fragmentation (Fig. 6 A to C).  
Examination of HDAC inhibitors Apicidin and Trichostatin revealed that pretreatment with 
these two inhibitors at the highest doses tested (1 µM and 0.1 µM, respectively) also inhibited 
the T. denticola-mediated increase in MMP-2 expression and activation as well as that of its 
activator complex, MT1-MMP/TIMP-2. However, as with EGCG, neither of these inhibitors 
affected FN fragmentation (data not shown).  
HMT, HDM and HAT inhibitors exacerbate T. denticola-mediated increases in MMP-2 
expression and activity in PDL cells. Inhibitors of histone demethylases (HDM), histone 
methyltransferases (HMT), and histone acetyltransferases (HAT) were not effective in 
preventing the T. denticola-mediated increases in pro-MMP-2 expression and activation. 
Treatment with Curcumin, a HAT inhibitor, resulted in moderately increased expression of pro-
MMP-2, but significantly decreased its MMP-2 activation in a dose-dependent manner (Fig. 7A). 
In contrast, the HDM inhibitor, Tranylcypromine, HCl (TCP) and the HMT inhibitor, BIX 
01295/ trihydrochloride hydrate further augmented the T. denticola-mediated increases in MMP-
2 expression and activation in PDL cells (Fig. 7B, C). 
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Inhibitors of histone phosphorylation and histone deacetylase reverse T. denticola-
mediated increases in MMP-2 activity and expression in PDL cells. An important remaining 
question was whether existing epigenetic modifications on periodontal ligament cells mediated 
by T. denticola could be reversed in a post-treatment scenario. To this end, periodontal ligament 
cells were first challenged with T. denticola then the same enzyme inhibitors tested above were 
employed to address this question. In agreement with the pretreatment results, post-treatment of 
T. denticola challenged PDL cells with three different epigenetic enzyme inhibitors reversed the 
effects on MMP-2 expression and activation: the histone kinase inhibitor, PF-03814735 (Fig. 
8A) and the HDAC inhibitors apicidin (Fig. 8B) and trichostatin (Fig. 8C).  
It is important to note that the results of the pre- and post-challenge inhibition experiments 
should not be compared in parallel because of different sample collection times used. In the pre-
treatment experiments, samples were collected after 3 days of a T. denticola (2-hour exposure) 
challenge, whereas in the post-challenge treatment experiments, the samples were collected 2 
hours to 4 days after a T. denticola (2 hour exposure) challenge, depending on the inhibitor used. 
Similarly, in contrast to the pre-challenge enzyme inhibition experiments, no decrease in FN 
fragmentation was observed in post-challenge inhibition experiments (data not shown), 
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ECM destruction, a key event in the pathogenesis of periodontitis, is mediated by host-derived 
enzymes such as MMP-2 that are involved in ECM homeostasis and remodeling. Strong 
evidence has accumulated over the past two decades that bacterial components, including 
proteases and lipopolysaccharides, are key factors contributing to dysregulation of ECM 
homeostasis. It is of particular interest that activation of pro-MMP-2, which is constitutively 
expressed in PDL cells, is required for the fragmentation of cellular FN that is typically seen in 
periodontal disease (Miao et al., 2011). Thus, identifying factors that control MMP-2 expression 
or activation can help us better understand and modulate periodontal disease pathogenesis.  
T. denticola is a member of a very complex microbiota involved in the pathogenesis of 
periodontal diseases. MMP-2 production and activation is a major event in the pathogenesis of 
these diseases via its role in extracellular matrix destruction. The T. denticola dentilisin protease 
plays an important role in the up-regulation and activation of MMP-2 in PDL cells (Miao et al., 
2011, Miao et al., 2014), thereby promoting further ECM destruction and release of fibronectin 
fragments, which have deleterious effects on the periodontal environment (Kapila et al., 1996, 
Kapila et al., 1999, Kapila et al., 2002, Jee et al., 2004, Dai et al., 2005, Tafolla et al., 2005, 
Ghosh et al., 2008, Joo et al., 2008, Joseph et al., 2010, Miao et al., 2011, Miao et al., 2014, 
Pereira et al., 2014). The oral spirochete T. lecithinolyticum is also reported to activate MMP-2, 
as are P. gingivalis and A. actinomycetemcomitans (Choi et al., 2001, Chang et al., 2002, Song et 
al., 2003). The molecular mechanism(s) involved remain unstudied or unresolved for these 
species.  
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T. denticola dentilisin activity was present for several days in PDL cell conditioned medium, 
long after the brief (2 hour) challenge, washing and multiple changes of growth medium. This is 
consistent with our prior reports (Miao et al., 2011, Miao et al., 2014) and is likely due to 
persistent adherence of T. denticola to PDL cells, though we cannot yet rule out potential 
downstream effects of previously documented uptake of T. denticola by PDL cells (Miao et al., 
2014) and gingival epithelial cells (Shin et al., 2012, Jo et al., 2014, Inagaki et al., 2016). 
Importantly, while dentilisin activity levels decreased steadily over time, MMP-2 and its 
activating complex, MT1-MMP and TIMP-2, were clearly expressed and activated through the 
12th day of culture. These data confirm our previous results that dentilisin is an important factor 
in the activation of pro-MMP-2 (Miao et al., 2011). Additionally, in agreement with our earlier 
findings (Miao et al., 2014), the current data show that T. denticola chronically activates MMP-
2, in concert with MT1-MMP and TIMP-2 expression up to 12 days. Importantly, degradation of 
cellular FN in PDL cell cultures is dependent on MMP-2 activation, which is the result of T. 
denticola dentilisin activity (Miao et al., 2011). The persistent fibronectin fragmentation in these 
samples may help explain the chronicity of tissue destruction mediated by bacterial proteases 
during periodontal disease pathogenesis.  
Previous studies showed that T. denticola has the ability to adhere to and be internalized by 
several different host cells, including gingival epithelial cells, PDL cells, and polymorphonulear 
leukocytes (Ding et al., 1997, Konermann et al., 2012, Shin et al., 2012, Miao et al., 2014). It 
should be noted that, unlike other oral pathogens, such as Porphyromonas gingivalis which 
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exhibits a cellular-invasive phenotype (Lamont et al., 1995), there is no reported evidence that T. 
denticola survives in the intracellular environment. Taken in aggregate, these results and the 
findings from this study, support the concept that the alteration of the PDL cells towards a 
destructive phenotype is a consequence of exposure to T. denticola. These data are consistent 
with evidence from other inflammatory diseases pointing toward an epigenetic role in the 
pathogenic process. We hypothesized that epigenetic mechanisms may imprint the periodontium 
and set in motion the process of chronic periodontal tissue destruction.  
Mechanisms of epigenetic modifications include, histone acetylation, histone methylation, 
DNA methylation, positioning of histone variants, and gene regulation by non-coding micro 
RNAs (miRNAs) (Bayarsaihan, 2016, Herceg, 2016, Perkins et al., 2016). Several enzymes are 
involved in these mechanisms including; histone acetyltransferases (HATs), histone deacetylases 
(HDACs), histone methyltransferases (HMTs), histone demethylases (HDMs), histone 
phosphorylases, and DNA methyltransferases (DNMTs).  
Perturbing the balance between acetylation/deacetylation or methylation/demethylation is 
profoundly associated with numerous diseases including developmental abnormalities, cancer 
and chronic inflammatory conditions (Bird, 2002, Barros et al., 2009). Epigenetic modifications 
are potentially reversible; therefore, a thorough understanding of these changes may identify new 
therapeutic targets for disease management. Using gene arrays that target chromatin modification 
enzymes, our data provides the first evidence that T. denticola mediates downregulation of many 
of these enzymes in PDL cells. In similar studies, P. gingivalis lipopolysaccharides were shown 
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to downregulate many chromatin modification enzymes in cultured oral keratinocytes (de 
Camargo Pereira et al., 2013) and change the expression of multiple miRNAs in PDL cells (Du 
et al., 2016). However, since T. denticola-dependent MMP-2 activation requires dentilisin 
proteolytic activity (Miao et al., 2011), it is likely that the molecular mechanisms responsible for 
this downregulation differ from those driven by P. gingivalis lipopolysaccharides. Specific 
mechanisms by which T. denticola or its dentilisin protease may regulate epigenetic enzyme 
expression are under study in our laboratories.  
The association between T. denticola and periodontitis has been reported in numerous studies 
(Simonson et al., 1988, Sakamoto et al., 2001, Asai et al., 2002, Yoshida et al., 2004). 
Consistent with the existing literature, we found that T. denticola levels were significantly 
elevated in human tissue specimens from periodontally diseased sites compared with healthy 
sites, as measured by qPCR normalized to human GAPDH (data not shown). To date, studies of 
the role of epigenetic modifications in periodontal disease have focused on DNA methylation 
patterns in genes involved in inflammatory responses (Barros et al., 2014). The present study 
used gene array approaches to examine healthy and diseased periodontal tissues, revealing for 
the first time significant alterations in the expression of several chromatin modification enzymes 
in diseased tissues. Although expression levels of some enzymes (such as Aurora Kinase B) 
differed in the gene array of the PDL cells compared to the tissues, this likely reflects the fact 
that tissues exhibit the net expression of diverse cell types that comprise the periodontium, as 
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well as the net effects of the diverse oral microbiome on the periodontium, and net effects of 
other epigenetic effectors, including smoking and medications. 
Different inhibitors show promise in reversing epigenetic changes in the context of our study 
and in other reports. Chronic T. denticola-mediated MMP-2 expression and activation were 
decreased in T. denticola challenged PDL cells either pre- or post-treated with inhibitors of 
histone phosphorylases, histone deacetylases (HDACs), and DNA methyltransferases (DNMTs). 
This indicates that T. denticola induces epigenetic changes mediated by histone phosphorylation, 
histone deacetylation, or DNA methylation pathways. Specifically, pre- or post-treatment 
inhibition of histone phosphorylation in PDL cells using PF-03814735 significantly prevented or 
reversed the T. denticola-mediated increase in MMP-2 and the MT1-MMP/TIMP-2 complex. 
This study is the first to show the effect of inhibition of histone phosphorylation on MMP-2 
expression in PDL cells. In a broader context, PF has been used in phase I clinical trials for the 
treatment of advanced solid tumors (Jani et al., 2010, Schoffski et al., 2011).  
Inhibition of HDACs using Apicidin and/or Trichostatin was also effective in preventing or 
reversing the T. denticola-mediated effects on the expression of MMP-2 in PDL cells. Similar 
data were obtained by other studies investigating the effect of Trichostatin on MMP-2 expression 
in murine fibroblasts (Ailenberg et al., 2002). Trichostatin was further shown to decrease MMP-
2 and MMP-9 expression in murine heart cells (Mani et al., 2015) and in human esophageal 
squamous cell carcinoma cells (Wang et al., 2013). Trichostatin, in combination with SAHA, 
was reported to inhibit the respiratory syncytial virus (RSV)-mediated increase in HDAC2 
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expression with resultant decrease in airway inflammation and oxidative stress in vivo (Feng et 
al., 2016). Apicidin was also reported to inhibit the expression of MMP-2 in different cancer 
cells (Kim et al., 2000, Park et al., 2011, Ahn et al., 2012). On the other hand, inhibition of 
DNMTs using AZA showed a reduction in the expression of MMP-2 and its activating complex, 
while the use EGCG was not effective in this process.  
Our results are consistent with those in other studies reporting that AZA causes a down-
regulation of MMP-2 and MMP-9 expression in cultured esophageal squamous cell carcinoma 
cells (Liu et al., 2014) and breast cancer cells (Chang et al., 2014b) respectively. AZA was 
approved by the U. S. Food and Drug Administration (FDA) for treatment of myelodysplastic 
syndromes (Nebbioso et al., 2012). It was also investigated in many clinical trials for treatment 
of several disorders, including hematological and neoplastic disorders (Liu et al., 2005, Mirza et 
al., 2010, Chen et al., 2012). Regarding the effect of EGCG on MMP-2 expression in our study, 
the data are inconsistent with other studies, which reported the ability of EGCG to inhibit MMP-
2 in different cancer cells (Chang et al., 2014a, Nowakowska et al., 2016). This inconsistency 
may be due to the use of different cell types, different concentrations of EGCG, or both. 
Concentrations higher than 10 µM were toxic to PDL cells as examined by cell proliferation and 
cytotoxicity assays (data not shown). Due to the weak effect of EGCG on the expression of 
MMP-2, we did not test its effects in a post-challenge scenario. 
Negative consequences of using epigenetic enzyme inhibitors are possible, as seen in the 
current study. Specifically, some inhibitors, namely those inhibiting HDM with TCP and those 
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inhibiting HMT with BIX 01295, further increased MMP-2 expression and activation. Although 
TCP and BIX are thought to mediate opposite actions, namely BIX inhibits histone methylation 
and TCP promotes histone methylation, both increased MMP-2 expression and activation. Thus, 
due to these undesirable effects, BIX and TCP were not evaluated further in post-challenge 
scenarios. There are no previous studies investigating their effect on expression of MMPs. 
However, Pereira et al. showed that increases in MMP-2 expression were stimulated by 
decreases in histone methylation in the context of the MMP-2 promoter (Pereira et al., 2014). 
Additionally, in another study, the MMP-1, 3, 9, and 13 genes were shown to be actively 
transcribed in rheumatoid arthritis-derived synovial fibroblasts, and this transcription correlated 
with an elevation in H3K4me3 and suppression of H3K27me3 in the MMP promoter genes 
(Araki et al., 2016). These studies, which both showed increases in MMP-2 expression despite 
different degrees of histone methylation, can be explained by the fact that activation or 
repression of gene expression by histone modifications/methylations depends on the type of 
lysine being modified and the degree of its methylation. For example, H3K4me, H3K36me, or 
H3K79me are associated with transcriptional activation (Jenuwein et al., 2001, Zhang et al., 
2001, Barski et al., 2007, Guenther et al., 2007, Koch et al., 2007, Kouzarides, 2007), whereas 
H3K9me, H3K27me, or H4K20me are implicated in gene repression (Jenuwein et al., 2001, 
Nakayama et al., 2001, Talbert et al., 2006, Barski et al., 2007, Kouzarides, 2007).  
The HAT inhibitor curcumin also increased the expression of MMP-2 but significantly 
inhibited its activation. The effect of curcumin in decreasing MMP-2 and MMP-9 expression 
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levels was reported in cancer cells, such as squamous cell carcinoma and osteoclastoma (Cao et 
al., 2015, Lee et al., 2015). Additionally, in vivo studies in humans and animals demonstrated 
curcumin’s effectiveness in decreasing the severity of periodontal diseases (Elburki et al., 2014, 
Nagasri et al., 2015, Bakir et al., 2016, Elburki et al., 2016). Curcumin has been investigated in 
many clinical trials for treatment of several disorders, such as ulcerative colitis (Baliga et al., 
2012), breast cancer (Nagaraju et al., 2012), pancreatic cancer (Veeraraghavan et al., 2011), and 
diabetes (Abdel Aziz et al., 2012). Additional investigation into the role of curcumin in MMP 
activation and regulation in periodontal diseases is further warranted, given these reports and the 
current study findings. 
In summary, T. denticola plays a key role in the transcriptional regulation of MMP-2 and its 
activating complex MT1-MMP/TIMP-2 in PDL cells. T. denticola also mediates alterations of 
chromatin modification enzyme expresssion in PDL cells, and an array of epigenetic 
modifications are associated with periodontally diseased tissues. Furthermore, inhibition of 
enzymes that mediate epigenetic modifications can prevent T. denticola-mediated increases in 
MMP-2, MT1-MMP, and TIMP-2 in PDL cells. These inhibitors can also reverse the T. 
denticola-mediated effects on MMP-2 and its activating complex in PDL cells. These data 
indicate that T. denticola mediates its effects on MMP-2 activation through epigenetic 
modifications in these cells. This knowledge can be useful as a first step toward the development 
of novel targeted therapeutics for the treatment of periodontal diseases.  
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Materials and Methods 
Periodontal ligament (PDL) cell culture. As described previously, the primary culture of 
PDL cells was obtained via the direct cell outgrowth method by isolating cells from the PDL 
tissue around the middle third of extracted healthy human teeth (Scanlon et al., 2011, Tanaka et 
al., 2011). Cells were maintained in minimal essential medium-α (MEM-α) augmented with 10% 
fetal bovine serum (FBS), 1% penicillin/streptomycin (P/S), and 1% amphotericin B (Gibco, 
Grand Island, NY, USA) in a humid atmosphere with 95% air and 5% CO2 at 37°C. Cell 
outgrowths were passaged when they reached confluency. Cells passaged three to six times were 
used for experimentation. The cell counting kit-8 (Dojindo, Rockville, MD, USA) was used for 
assaying PDL cell proliferation and cytotoxicity at different time intervals in response to 
different concentrations of the inhibitors used in the study (data not shown). Protocols involving 
the collection and use of human teeth and PDL cells/tissue were approved by the Health Sciences 
Institutional Review Board of the University of Michigan.  
Human periodontal tissues. Periodontal tissues were obtained by collecting the tissues 
around the coronal third of the roots of extracted periodontally-involved teeth and healthy teeth, 
both from the posterior mandibular region. Periodontal status was diagnosed clinically by testing 
for bleeding on probing of the gingival sulcus and periodontal pocket depth measurements. The 
samples were collected from six different periodontitis patients and six healthy subjects. The 
collection and use of human teeth and PDL tissues was approved by the Health Sciences 
Institutional Review Board of the University of Michigan. 
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Culture of Treponema denticola. Treponema denticola ATCC 35405 was grown as 
described previously under anaerobic conditions at 37°C in New Oral Spirochete (NOS) broth 
medium (Haapasalo et al., 1991, Fenno, 2005). Purity of spirochete cultures was confirmed by 
darkfield microscopy prior to use in experiments.  
Challenge of PDL cells with Treponema denticola. PDL cells were prepared in MEM-α free 
of serum and antibiotics. The bacteria in broth culture were collected by centrifugation, then re-
suspended in serum- and antibiotic-free MEM-α to an optical density of 0.1 at 600 nm, such that 
the cellular density was approximately 2.4×108 cells/ml. 
T. denticola in serum-and antibiotic-free MEM-α was added to the test group of PDL cells 
(T. denticola group) at a multiplicity of infection (MOI) = 100, whereas only MEM-α was added 
to the control group. Both groups were then incubated for two hours at 37°C in 5% CO2-
containing air. After the two-hour challenge, PDL cells were washed three times with PBS and 
incubated for the planned time periods in serum-and antibiotic-free MEM-α with daily medium 
changes as described previously (Miao et al., 2011). Subsequently, the culture conditioned 
medium and cell lysates were collected, RNA was extracted from the cell lysates, and all 
samples were stored at ˗80°C for further investigations.  
Pre-challenge inhibition of epigenetic chromatin modification enzymes in PDL cells, 
Different inhibitors of epigenetic chromatin modification enzymes (listed in Table 1) were 
obtained and prepared according to the manufacturer’s instructions, then brought to the desired 
concentrations via dilution in serum- and antibiotic-free MEM-α. With the exception of 
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tranylcypromine (EMD Millipore, Temecula, CA, USA), all enzyme inhibitors were purchased from 
Sigma Aldrich (St. Louis, MO, USA). 
PDL cells were treated with the indicated concentrations of the enzyme inhibitors either as 
single agents or in combinations, and incubated for the indicated times with daily culture 
medium replacement. The cells were then challenged with T. denticola at an MOI of 1:100 for 2 
hours, washed, and incubated for three days in serum- and antibiotic-free MEM-α with daily 
culture medium refreshment. At the end of this incubation period, conditioned culture medium 
and cell lysates were harvested and stored at -80°C for further investigations.  
Post-challenge inhibition of epigenetic chromatin modification enzymes in PDL cells. For 
the post-challenge experiments, the PDL cells were first challenged with T. denticola as 
described before, then treated with the indicated concentrations of the inhibitors either as single 
agents or in combinations for certain periods. At the end of the treatment period, the conditioned 
culture medium and cell lysates were harvested and stored at -80°C for further investigations. All 
experiments were repeated at least three times and each experiment was performed in triplicate. 
Gelatin zymography. Culture supernatants were concentrated approximately 10-fold in 
Amicon centrifugal concentrators (10,000-molecular-weight cutoff; Millipore) and total protein 
concentration was measured using the BCA protein assay kit (Thermo Scientific, Rockford, IL, 
USA) normalized to an albumin standard. Equivalent protein concentrations from each sample 
were mixed with non-reducing sample buffer (0.25 M tris-base, 40% glycerol, 0.8% SDS, and 
0.05% bromophenol blue stain in distilled deionized water/ddH2O at pH 6.8) and loaded into 8% 
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polyacrylamide gels co-polymerized with 0.4% SDS and 0.2% gelatin. Samples were 
electrophoretically resolved on gelatin-containing gels at 125 V for 110 minutes at 4°C. Gels 
were then washed twice for 15 minutes under continuous agitation using renaturation/washing 
buffer (2.5% v/v Triton-X100 and 0.05 M Tris-base in ddH2O at pH 7.5) to eliminate SDS and 
promote the renaturation of MMP enzymes. Subsequently, gels were incubated in 
developing/incubation buffer (0.05 M Tris-base, 0.15 M sodium chloride, 0.01 M calcium 
chloride, and 0.02% sodium azide in ddH2O at pH 7.5) for 30 minutes under agitation, then the 
buffer was replaced and gels incubated for 16-20 hours at 37°C. After that, gels were stained 
using filtered Coomassie Brilliant blue stain for one or two hours under agitation. Destaining of 
the gels was performed using a methanol/acetic acid destaining buffer (40% methanol and 10% 
acetic acid in ddH2O) until the bands on the gel appeared clear. Zymograms were scanned and 
the densitometry of the gelatinolytic activity represented by the clear bands was analyzed using 
ImageJ software (NIH, USA). Brightness and contrast levels of zymogram images were slightly 
adjusted for publication only.  
Immunoblotting. Equivalent protein samples consisting of 10 fold concentrates of PDL cell 
culture conditioned media were standardized as described above, subjected to standard SDS-
PAGE (4-12% polyacrylamide gels; Invitrogen, Carlsbad, CA, USA) and transferred to PVDF 
membranes using standard techniques. The membranes were exposed to a rabbit polyclonal anti-
fibronectin IgG (Santa Cruz, Dallas, TX, USA) primary antibody diluted 1:2000 in TBST 
solution for 2 hours at room temperature followed by a horseradish peroxidase (HRP)-conjugated 
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goat anti-rabbit IgG secondary antibody (Santa Cruz, Dallas, TX, USA) diluted 1:10,000 in 
TBST for 1 hour at room temperature with agitation. Western blots using anti-GAPDH 
antibodies were used to further confirm equal protein loading (data not shown). Blots were 
developed using the SuperSignal® West Pico kit (ThermoFischer Scientific, Pittsburgh, PA, 
USA) and scanned for digitization. 
Quantitative reverse transcriptase PCR (qRT-PCR). qRT‐PCR was performed to assess 
the transcriptional levels of MMP-2, MT1-MMP, and TIMP-2 in PDL cells. Cell lysates were 
collected and the RNA was extracted and purified using the RNeasy® mini kit (Qiagen, Valencia, 
CA, USA) according to the manufacturer’s instructions. Reverse transcription of the RNA into 
cDNA was then performed using the SuperScript™ II RT kit (Invitrogen, Carlsbad, CA, USA). 
The cDNA was then amplified by qPCR using the TaqMan® Universal PCR Master Mix 
(Invitrogen, Carlsbad, CA, USA)” on a ViiA™ 7 Applied Biosystems® PCR system. The 
following TaqMan® human probes were used; MMP-2 (Hs01548727_m1), MT1-MMP 
(Hs01037003_g1), TIMP-2 (Hs00234278_m1), and GAPDH (Hs03929097_g1) (Invitrogen, 
Carlsbad, CA, USA). The cycle threshold (Ct) values were obtained, analyzed and the 
quantitative expression of target genes in challenged PDL cells was normalized to GAPDH and 
compared to the control cells using the 2−ΔΔCT method (Livak et al., 2001), applying a minimum 2 
fold change in expression as the cut off.   
Similar methodology was utilized to assess the levels of MMP-2 transcription and the levels 
of T. denticola in human periodontal tissue samples. Periodontal tissue specimens were collected 
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by scraping the most coronal portion of the tissue around the roots of extracted healthy and 
periodontally-diseased teeth. Total RNA was extracted from healthy and diseased periodontal 
tissue specimens and cDNA was generated. Target genes were amplified using TaqMan® 
Universal PCR Master Mix (Invitrogen, Carlsbad, CA, USA). Tissue sample human genome 
content was normalized using a custom TaqMan® primer/probe set for GAPDH 
(Hs03929097_g1; Invitrogen, Carlsbad, CA, USA). T. denticola 16S rRNA was amplified in 
parallel using the SYBR® Green PCR Master Mix (Invitrogen, Carlsbad, CA, USA) with the 
following primer set: 16SrRNA-987F AGGGATATGGCAGCGTAGCA and 16SrRNA-1077R 
TTGCGGGACTTAACCCAACA.  
Quantitative reverse transcription (qRT-PCR) gene micro-array. qRT-PCR arrays were 
used to assess the transcriptional levels of the main epigenetic chromatin modification enzymes 
in cultured PDL cells and in periodontal tissues using the RT2 Profiler PCR Array kit (Qiagen, 
Valencia, CA, USA) to assay transcription of the genes listed in Table S1. Periodontal tissue 
specimens were collected by scrapping the most coronal portion of the tissue around the roots of 
extracted healthy and periodontally-diseased teeth. RNA was extracted and purified from PDL 
cell cultures using the RNeasy® Mini kit, while extraction and purification of RNA from 
periodontal tissues was achieved using the RNeasy® Protect Mini kit (Qiagen, Valencia, CA, 
USA) according to the manufacturer’s protocol. Reverse transcription of RNA into cDNA was 
performed using the RT2 First Strand Kit (Qiagen, Valencia, CA, USA). The target genes were 
then amplified using the RT2 Profiler PCR Array kit and RT2 SYBR® Green Master mix 
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(Qiagen, Valencia, CA, USA) on a ViiA™ 7 Applied Biosystems® PCR system. Applying a 
minimum 2 fold change in expression as the cut off, Ct values were analyzed and the quantitative 
expression of the genes of interest in T. denticola-challenged PDL cells was normalized to 
supplied housekeeping genes; β-actin, Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), β-
2-microglobulin, Hypoxanthine phosphoribosyltransferase-1, and large ribosomal protein-P0 and 
then compared to expression levels in unchallenged PDL cells and the healthy tissues (Livak et 
al., 2001). 
Statistical analysis. The data were analyzed using the statistical software SPSS® v.22 (IBM, 
Armonk, NY, USA). Results were evaluated by a one-way ANOVA when comparing more than 
two groups, whereas the student’s t-test was used when comparing two groups. p < 0.05 was 
considered significant, whereas p < 0.001 was considered highly significant. 
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  Table 1. Chemical agents used to target chromatin modification enzymes. 
Compound Target enzyme 
Concentrations 
(µM) Treatment period Source References Low High 
Inhibition of DNA methyltransferases (DNMT)    



















Inhibition of Histone Deacetylases (HDACs) 





Apicidin - HDAC 0.5 1 1 day * 




Inhibition of Histone phosphorylation 
PF-03814735 - AURK A 
- AURK B  0.25 0.5 2 days 
* (Hook et al., 2012) 
Inhibition of Histone Acetyltransferases (HATs)    










Inhibition of Histone Methyltransferases (HMTs) 
   
BIX 01294      - HMT G9a 0.5 1 2 days * (Kubicek et al., 2007) 




oxidase A/B  
Histone LSD1/2  
2 5 4 days # 
(Nebbioso 
et al., 2012) 
* Sigma-Aldrich, St. Louis, MO, USA 
# EMD Millipore, Temecula, CA, USA 
  





Figure 1. T. denticola mediates chronic expression and activation of MMP-2, MT1-MMP, 
and TIMP-2 in PDL cells, with subsequent fragmentation of cellular fibronectin. Cultured 
PDL cells were challenged with T. denticola (Td) at MOI = 100 or media control for two hours, 
then incubated for 3, 6, 9, and 12 days with daily medium changes. The experiments were 
repeated three times in triplicate. Data were analyzed using one-way ANOVA. (*) represents p < 
0.05 compared to the same time point in the control group. (#) represents p < 0.001 compared to 
the same time point in the control group. 
Panel A: A representative gelatin zymogram of PDL cell conditioned medium showing the 
gelatinolytic activity of pro-MMP-2 (72-kDa), active MMP-2 (64-kDa), and Td dentilisin (100-
kDa). The left 4 lanes represent the control unchallenged PDL cells and the right 4 lanes 
represent the Td-challenged PDL cells. The bar chart below represents the densitometric 
analysis of gelatinolytic activity in the zymograms using ImageJ™-NIH software. The Y-axis 
represents fold-gelatinolytic activity of the pro-MMP-2, active MMP-2, and dentilisin relative 
to unchallenged control at day 3. The X-axis represents different time points. 
Panel B: A representative immunoblot of PDL cell culture supernatants probed with a 
polyclonal anti-fibronectin antibody showing FN fragmentation in conditioned medium from 
Td-challenged PDL cells.  
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Panel C: Transcript levels of MMP-2, MT1-MMP, and TIMP-2 in PDL cells at different time 
points after challenge with Td or media control assayed by qRT-PCR. The Y-axis represents 
fold-expression level of each gene relative to unchallenged control at day 3. The X-axis 
represents different time points. 
Figure 2. Elevated MMP-2 mRNA and T. denticola in diseased periodontal tissue. Levels of 
T. denticola 16S rRNA and MMP-2 mRNA in tissue specimens from periodontally diseased or 
healthy sites were assayed by qRT-PCR. The Y-axis represents levels of each RNA in 
periodontitis specimens relative to healthy specimens. The X-axis represents the source of tissue 
specimens. Data were analyzed using Student’s t-test. (#) represents p < 0.001 compared to 
healthy tissue. 
Figure 3. Transcription of multiple chromatin modification enzymes is altered in both 
periodontally diseased tissue and in T. denticola-challenged PDL cells. Transcription levels 
of 87 chromatin modification enzymes were examined by qRT-PCR using RNA extracted from 
healthy and diseased periodontal tissues (Panels A and B, respectively) and from PDL cell 
lysates collected 9 days after Td challenge as described in Fig. 1 (Panels C and D, respectively).  
Panels A and C: Scatter blots showing the transcriptional level of chromatin modification 
enzymes in periodontally diseased tissues relative to healthy tissue controls (Panel A) and in 
Td-challenged PDL cells relative to unchallenged control cells (Panel C). The Y-axis 
represents expression level of different enzymes relative to healthy tissue (Panel A) or 
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unchallenged control cells (Panel C). The X-axis represents normalized expression of the 
respective control group. 
Panels B and D: Bar-charts showing the significantly downregulated chromatin modification 
enzymes in periodontally diseased tissues relative to healthy tissue controls (Panel B) and in 
Td-challenged PDL cells relative to unchallenged control cells (Panel D). The Y-axis 
represents the fold-expression/downregulation level of enzymes relative to unchallenged 
controls. The X-axis represents different chromatin modification enzymes, with enzyme type 
grouped by color. 
 
Figure 4. Inhibition of histone phosphorylation using PF-03814735 results in decreased 
expression and activation of MMP-2, MT1-MMP and TIMP-2, and decreased fibronectin 
fragmentation in T. denticola-challenged and control PDL cells. Cultured PDL cells were pre-
treated with 0.25 or 0.5 µM PF-03814735 (PF) for two days. The cells were then challenged with 
T. denticola (Td) at MOI = 100 or media control for two hours then incubated for three days. The 
conditioned medium and cell lysates were collected for zymography, western blotting, and qRT-
PCR. The experiments were repeated three times in triplicate. Data were analyzed using one-way 
ANOVA. (*) represents p < 0.05 compared to the “0” concentration in the same group. (#) 
represents p < 0.001 compared to the “0” concentration in the same group. 
Panel A: Densitometric analysis of pro-MMP-2 (72kDa) and active MMP-2 (64kDa) detected 
by gelatin zymography. The X-axis represents different concentrations of histone 
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kinase/phosphorylation inhibitor, PF-03814735 (PF) in the control and Td groups. The Y-axis 
represents fold-gelatinolytic activity of the pro-MMP-2 and active MMP-2 relative to 
unchallenged and untreated controls. 
Panel B: A representative immunoblot of PDL cell culture supernatants probed with a 
polyclonal anti-fibronectin antibody showing FN fragmentation in conditioned medium from 
Td-challenged PDL cells, control and PF-treated. 
Panel C: Bar chart showing transcript levels of MMP-2, MT1-MMP and TIMP-2 in the control 
and PF-treated PDL cells as determined by qRT-PCR. The Y-axis represents fold-expression 
level of each gene relative to unchallenged and untreated controls. The X-axis represents 
different concentrations of PF in the control and Td groups. 
 
Figure 5. Inhibition of DNA methyltransferases using AZAcytidine (AZA) result in 
decreased expression and activation of MMP-2, MT1-MMP and TIMP-2, and decreased 
fibronectin fragmentation in T. denticola-challenged and control PDL cells. Cultured PDL 
cells were pre-treated with 1 or 5 µM AZA for four days. The cells were then challenged with T. 
denticola (Td) at MOI = 100 or media control for two hours then incubated for three days. The 
conditioned medium and cell lysates were collected for zymography, western blotting, and qRT-
PCR. The experiments were repeated three times in triplicate. 
Panel A: Densitometric analysis of pro-MMP-2 (72kDa) and active MMP-2 (64kDa) detected 
by gelatin zymography. The X-axis represents different concentrations of DNA 
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methyltransferases inhibitor Azacytidine (AZA) in the control and Td groups. The Y-axis 
represents fold-gelatinolytic activity of the pro-MMP-2 and active MMP-2 relative to 
unchallenged and untreated controls. Data were analyzed using one-way ANOVA. (*) 
represents p < 0.05 compared to the “0” concentration in the same group. (#) represents p < 
0.001 compared to the “0” concentration in the same group. 
Panel B: A representative immunoblot of PDL cell culture supernatants probed a polyclonal 
anti-fibronectin antibody showing FN fragmentation in conditioned medium from Td-
challenged PDL cells, control and AZA-treated. 
Panel C: Bar chart showing transcript levels of MMP-2, MT1-MMP and TIMP-2 in the control 
and AZA-treated PDL cells as determined by qRT-PCR. The Y-axis represents fold-expression 
level of each gene relative to unchallenged and untreated controls. The X-axis represents 
different concentrations of AZA in the control and Td groups. 
 
Figure 6. Inhibition of DNA methyltransferases using epigallocatechin gallate (EGCG) 
mediate a decrease in MMP-2 activation, an increase in TIMP-2 transcription and minimal 
decrease in fibronectin fragmentation in Td-challenged PDL cells. Cultured PDL cells were 
pre-treated with 5 or 10 µM EGCG for two days before being challenged with T. denticola (Td) 
at MOI = 100 or media control for two hours, then incubated for three days. The conditioned 
medium and cell lysates were collected for zymography, western blotting, and qRT-PCR. The 
experiments were repeated three times in triplicate. Data were analyzed using one-way ANOVA. 
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(*) represents p < 0.05 compared to the “0” concentration in the same group. (#) represents p < 
0.001 compared to the “0” concentration in the same group. 
Panel A: Densitometric analysis of pro-MMP-2 (72kDa) and active MMP-2 (64kDa) 
detected by gelatin zymography. The left 3 lanes represent the control group (unchallenged 
PDL cells) and the right 3 lanes represent the Td group (Td-challenged PDL cells). The cells 
in both groups were treated with indicated concentrations of EGCG. The X-axis represents 
different concentrations of EGCG in the control and Td groups. The Y-axis represents fold-
gelatinolytic activity of pro-MMP-2 and active MMP-2 relative to unchallenged and 
untreated controls.  
Panel B: A representative immunoblot of PDL cell culture supernatants probed with a 
polyclonal anti-fibronectin antibody showing FN fragmentation in conditioned medium from 
Td-challenged PDL cells, control and EGCG-treated. 
Panel C: Bar chart showing transcript levels of MMP-2, MT1-MMP and TIMP-2 in the 
control and ECGC-treated PDL cells as determined by qRT-PCR. The Y-axis represents 
fold-expression level of each gene relative to unchallenged and untreated controls. The X-
axis represents different concentrations of ECGC in the control and Td groups.  
Figure 7. Inhibition of different chromatin modification enzymes mediate alterations in 
levels of expression and activation of MMP-2 in Td-challenged and control PDL cell 
cultures. PDL cells were pre-treated with enzyme inhibitors at the indicated concentrations as 
follows: curcumin (histone acetyltransferase inhibitor) for two hours (A), 0.5 µM and 1 µM BIX-
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01294 (histone methyltransferase inhibitor) for two days (B), and 2 µM and 5 µM 
tranylcypromine/TCP (histone demethylase inhibitor) for four days (C). The cells were then 
challenged with T. denticola (Td) at MOI = 100 or media control for two hours, then incubated 
for three days. The conditioned medium and cell lysates were collected for zymography. Shown 
are densitometric analyses of pro-MMP-2 (72kDa) and active MMP-2 (64kDa) detected by 
gelatin zymography. The X-axis represents different concentrations of enzyme inhibitors in the 
control and Td groups. The Y-axis represents fold-gelatinolytic activity of the pro-MMP-2 and 
active MMP-2 relative to unchallenged and untreated controls. Panels: A, curcurmin (Cr); B, 
BIX-01294 (BIX); C, tranylcypromine (TCP). The experiments were repeated three times in 
triplicate. Data were analyzed using one-way ANOVA. (*) represents p < 0.05 compared to the 
“0” concentration in the same group. (#) represents p < 0.001 compared to the “0” concentration 
in the same group. 
Figure 8. Inhibitors of histone phosphorylases and deacetylases reverse T. denticola-
mediated increases in MMP-2 activity and expression in PDL cells. Cultured PDL cells were 
challenged with T. denticola (Td) at MOI = 100 or media control for two hours, incubated for 
three days in serum- and antibiotic-free MEM-α with daily culture medium refreshment, then 
treated with the following enzyme inhibitors: (Panel A) 0.25 or 0.5 µM PF-03814735 (PF) for 
two days; (Panel B) 0.5 or 1 µM apicidin for one day; (Panel C) 0.05 or 0.1 µM trichostatin A 
(TsA) for four days. The conditioned medium and cell lysates were collected for zymography, 
western blotting, and qRT-PCR. The left portion of each panel shows densitometric analysis of 
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pro-MMP-2 (72kDa) and active MMP-2 (64kDa) detected by gelatin zymography. The X-axis 
represents different concentrations of the indicated inhibitor in the control and Td-challenged 
cultures. The Y-axis represents fold-gelatinolytic activity of the pro-MMP-2 and active MMP-2 
relative to unchallenged and untreated controls. The right panel shows transcript levels of MMP-
2, MT1-MMP and TIMP-2 in the control and inhibitor-treated PDL cells as determined by qRT-
PCR. The Y-axis represents fold-expression level of each gene relative to unchallenged and 
untreated controls. The X-axis represents different concentrations of PF in the control and Td 
groups. The experiments were repeated three times in triplicate. Data were analyzed using one-
way ANOVA. (*) represents p < 0.05 compared to the “0” concentration in the same group. (#) 
represents p < 0.001 compared to the “0” concentration in the same group. 
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